NASDAQ: TVRDTvardi Therapeutics Inc Stock Ownership - Who owns Tvardi Therapeutics?
Insider buying vs selling
Have Tvardi Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when TVRD insiders and whales buy or sell their stock.
TVRD Shareholders
What type of owners hold Tvardi Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Csl Ltd | 55.45% | 7,396,770 | $13.68M | Insider |
| Vifor International Ltd | 55.45% | 7,396,770 | $13.68M | Insider |
| Dean Slagel | 29.43% | 3,925,825 | $7.26M | Insider |
| Rho Ventures VI LP | 26.75% | 3,568,057 | $6.60M | Insider |
| Martin Vogelbaum | 26.08% | 3,479,064 | $6.44M | Insider |
| Charles Phd Moller | 11.82% | 1,576,404 | $2.92M | Insider |
| Derek T. Chalmers | 7.43% | 991,405 | $1.83M | Insider |
| Shaheen Wirk | 3.32% | 443,385 | $820.26k | Insider |
| Samuel David Tweardy | 2.37% | 315,658 | $583.97k | Insider |
| Michael E. Lewis | 2.36% | 314,988 | $582.73k | Insider |
TVRD vs Biotech Stocks
Tvardi Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.